KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Total Debt (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.98%
Dec 31, 2025 0.03%
Sep 30, 2025 -2.88%
Jun 30, 2025 -2.05%
Mar 31, 2025 -4.52%
Dec 31, 2024 -0.50%
Sep 30, 2024 -3.59%
Jun 30, 2024 -2.15%
Mar 31, 2024 -0.92%
Dec 31, 2023 6.85%
Sep 30, 2023 -1.75%
Jun 30, 2023 -0.08%
Mar 31, 2023 58.16%
Dec 31, 2022 0.62%
Sep 30, 2022 5.97%
Jun 30, 2022 -0.90%
Mar 31, 2022 10.64%
Dec 31, 2021 -11.36%
Sep 30, 2021 14.63%
Jun 30, 2021 0.30%
Mar 31, 2021 -0.91%
Dec 31, 2020 -3.79%
Sep 30, 2020 0.18%
Jun 30, 2020 7.46%
Mar 31, 2020 6.50%
Dec 31, 2019 0.38%
Sep 30, 2019 -2.69%
Jun 30, 2019 -7.30%
Mar 31, 2019 -2.67%
Dec 31, 2018 -1.45%
Sep 30, 2018 -0.20%
Jun 30, 2018 -2.94%
Mar 31, 2018 0.56%
Dec 31, 2017 -1.21%
Sep 30, 2017 2.04%
Jun 30, 2017 2.85%
Mar 31, 2017 -1.46%
Dec 31, 2016 -2.06%
Sep 30, 2016 6.32%
Jun 30, 2016 -3.16%
Mar 31, 2016 9.16%
Dec 31, 2015 -1.05%
Sep 30, 2015 -0.60%
Jun 30, 2015 5.31%
Mar 31, 2015 -1.22%
Dec 31, 2014 -6.87%
Sep 30, 2014 -1.04%
Jun 30, 2014 12.90%
Mar 31, 2014 -8.12%
Dec 31, 2013 18.21%
Sep 30, 2013 13.68%
Jun 30, 2013 0.10%
Mar 31, 2013 -0.62%
Dec 31, 2012 0.06%
Mar 31, 2010 55.41%
Dec 31, 2009 0.00%
Sep 30, 2009 0.02%